Pacira BioSciences (PCRX) FCF Margin (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly FCF Margin of 13.71% for Q1 2026, down 683.0% year-over-year from 2.35% in Q1 2025, and down 37.91% quarter-over-quarter from 22.08% in Q4 2025.
Pacira BioSciences (PCRX) FCF Margin (2010 - 2026) Analysis & Trends
Pacira BioSciences' FCF Margin history runs 17 years deep, the most recent figure standing at 13.71% for Q1 2026.
- In Q1 2026, FCF Margin fell 683.0% year-over-year to 13.71%; the TTM figure through Mar 2026 stood at 17.19% (down 701.0% YoY), while the FY2025 annual figure was 18.81%, down 741.0% from the prior year.
- FCF Margin for Q1 2026 stood at 13.71%, down from 22.08% in the prior quarter.
- The five-year high for FCF Margin was 31.73% in Q3 2025, with the low at 7.42% in Q4 2022.
- The 5-year median for FCF Margin is 20.54% (2025), against an average of 18.66%.
- The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 3963 bps in 2022, then soared 2613 bps in 2023.
- Pacira BioSciences' FCF Margin stood at 7.42% in 2022, then soared by 352 bps to 18.7% in 2023, then grew by 3 bps to 19.27% in 2024, then climbed by 15 bps to 22.08% in 2025, then plunged by 38 bps to 13.71% in 2026.
- Business Quant data shows PCRX's FCF Margin at 13.71% in Q1 2026, 22.08% in Q4 2025, and 31.73% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Pacira BioSciences | 945.51 Mn | 694.48 Mn | 148.24 Mn | 29.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.17% |
| Mar 31, 2026 | 13.71% |
| Dec 31, 2025 | 22.08% |
| Sep 30, 2025 | 31.73% |
| Jun 30, 2025 | 0.85% |
| Mar 31, 2025 | 20.54% |
| Dec 31, 2024 | 19.27% |
| Sep 30, 2024 | 29.56% |
| Jun 30, 2024 | 27.76% |
| Mar 31, 2024 | 29.02% |
| Dec 31, 2023 | 18.70% |
| Sep 30, 2023 | 27.67% |
| Jun 30, 2023 | 25.59% |
| Mar 31, 2023 | 10.53% |
| Dec 31, 2022 | -7.42% |
| Sep 30, 2022 | 22.38% |
| Jun 30, 2022 | 9.83% |
| Mar 31, 2022 | 15.53% |
| Dec 31, 2021 | 13.26% |
| Sep 30, 2021 | 62.00% |